{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:54:26Z","timestamp":1789178066584,"version":"build-2803163510"},"reference-count":34,"publisher":"SLACK, Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Ophthalmol Strabismus"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>Limited information is available on the ocular findings in patients with Pompe disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>This study summarizes this information with a systematic literature review; reports the ocular histologic findings seen in a deceased infant with Pompe disease who was receiving enzyme replacement therapy and in a deceased adult with late-onset Pompe disease; and notes the new observation of ptosis in children with infantile-onset Pompe disease who are receiving enzyme replacement therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Six articles were found on the ultrastructural-histopathologic eye findings in Pompe disease. Previously reported clinical ocular findings included strabismus and ptosis. Glycogen accumulation and vacuolar myopathy have been seen histologically.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Based on these clinical and histologic reports, patients with Pompe disease may have an increased incidence of ocular abnormalities, such as ptosis and strabismus, and therefore should undergo ophthalmologic examination.<\/jats:p>\n            <jats:p>\n              <jats:bold>[J Pediatr Ophthalmol Strabismus 2010;47:34\u201340.]<\/jats:bold>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/01913913-20100106-08","type":"journal-article","created":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T16:30:43Z","timestamp":1265214643000},"page":"34-40","source":"Crossref","is-referenced-by-count":36,"title":["Clinical and Histologic Ocular Findings in Pompe Disease"],"prefix":"10.3928","volume":"47","author":[{"given":"Tammy L.","family":"Yanovitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhrad G.","family":"Banugaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Proia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.2174\/1566524024605789"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.01.053"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0519-9"},{"issue":"76","key":"e_1_3_1_5_2","first-page":"304","article-title":"Over idiopatische hypertrophie van het hart","author":"Pompe JC","year":"1932","unstructured":"Pompe JC. Over idiopatische hypertrophie van het hart. Ned Tijdshr Geneeskd. 1932;76:304.","journal-title":"Ned Tijdshr Geneeskd"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj0860011"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(65)80041-5"},{"key":"e_1_3_1_8_2","first-page":"1139","article-title":"An electron microscopic and biochemical study of type II glycogenosis","volume":"13","author":"Baudhuin P","year":"1964","unstructured":"Baudhuin P, Hers HG, Loeb H. An electron microscopic and biochemical study of type II glycogenosis. Lab Invest. 1964;13:1139\u20131152.","journal-title":"Lab Invest"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.gim.0000218152.87434.f3"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2000.107112"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh384"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.2.332"},{"key":"e_1_3_1_13_2","volume-title":"Myozyme (package insert)","year":"2006","unstructured":"Myozyme (package insert). Cambridge, MA: Genzyme Corporation; 2006."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2004.10.009"},{"key":"e_1_3_1_15_2","volume-title":"Presented at the 60th Annual Meeting of the American Academy of Neurology","author":"van der Ploeg A","unstructured":"van der Ploeg A, Clemens P, Corzo D, Escolar D, Florence J, Laforet P. Results from a randomized, double-blind multicenter, multinational, placebo-controlled study of the safety and efficacy of Myozyme, recombinant human acid alpha-glucosidase (rh-GAA), for the treatment of Pompe disease in juveniles and adults [abstract]. Presented at the 60th Annual Meeting of the American Academy of Neurology; April 12\u201319, 2008; Chicago, IL."},{"key":"e_1_3_1_16_2","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano A","year":"2001","unstructured":"Amalfitano A, Bengur AR, Morse RP. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial. Genet Med. 2001;3:132\u2013138.","journal-title":"Genet Med"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010383421286"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.5.e448"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2004.10.009"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.02.035"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000251268.41188.04"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.gim.0000217786.79173.a8"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-007-0428-y"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2003.12.018"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(72)90468-0"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000308694"},{"key":"e_1_3_1_27_2","first-page":"50","article-title":"Adult-onset acid maltase deficiency with prominent bulbar involvement and ptosis","volume":"86","author":"Barnes D","year":"1993","unstructured":"Barnes D, Hughes RA, Spencer GT. Adult-onset acid maltase deficiency with prominent bulbar involvement and ptosis. J R Soc Med. 1993;86:50.","journal-title":"J R Soc Med"},{"key":"e_1_3_1_28_2","first-page":"139","article-title":"Surgical treatment of myogenic blepharoptosis","volume":"255","author":"De Wilde F","year":"1995","unstructured":"De Wilde F, D'Haens M, Smet H, Martin JJ, Tassignon MJ. Surgical treatment of myogenic blepharoptosis. Bull Soc Belge Ophtalmol. 1995;255:139\u2013146.","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000249183.39952.3e"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000270101.95790.fb"},{"key":"e_1_3_1_31_2","first-page":"313","article-title":"[Eye histopathology study of a case of generalized glycogenosis (Pompe disease).]","volume":"137","author":"Toussaint D","year":"1964","unstructured":"Toussaint D, Danis P. [Eye histopathology study of a case of generalized glycogenosis (Pompe disease).]. Bull Soc Belge Ophtalmol. 1964;137:313\u2013325.","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880100311"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.61.7.476"},{"key":"e_1_3_1_34_2","first-page":"25","article-title":"Ultrastructure of the eye in fetal type II glycogenosis (Pompe's disease)","volume":"22","author":"Pokorny KS","year":"1982","unstructured":"Pokorny KS, Ritch R, Friedman AH, Desnick RJ. Ultrastructure of the eye in fetal type II glycogenosis (Pompe's disease). Invest Ophthalmol Vis Sci. 1982;22:25\u201331.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_1_35_2","volume-title":"Binocular Vision and Ocular Motility: Theory and Management of Strabismus","author":"von Noorden G","year":"2001","unstructured":"von Noorden G. Binocular Vision and Ocular Motility: Theory and Management of Strabismus, 6th ed. St. Louis: Mosby; 2001:1974.","edition":"6"}],"container-title":["Journal of Pediatric Ophthalmology &amp; Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/01913913-20100106-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T20:21:05Z","timestamp":1685564465000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/01913913-20100106-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.3928\/01913913-20100106-08"],"URL":"https:\/\/doi.org\/10.3928\/01913913-20100106-08","relation":{},"ISSN":["0191-3913","1938-2405"],"issn-type":[{"value":"0191-3913","type":"print"},{"value":"1938-2405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}